XBiotech Inc. — Director's Dealing 2018

Nov 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-11-09

Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-09	Common Stock	P	2200	$3.735	Acquired	2200	Indirect
2018-11-12	Common Stock	P	700	$3.75	Acquired	2900	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3398600	Direct
Common Stock	11500	Indirect
Common Stock	100000	Indirect